These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 25316523)
21. Changes in allele frequencies of Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656 [No Abstract] [Full Text] [Related]
22. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Tefferi A; Thiele J; Vannucchi AM; Barbui T Leukemia; 2014 Jul; 28(7):1407-13. PubMed ID: 24441292 [TBL] [Abstract][Full Text] [Related]
23. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia. Drexler HG; Nagel S; Quentmeier H Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566 [TBL] [Abstract][Full Text] [Related]
24. Current strategies in the diagnosis and management of chronic neutrophilic leukemia. Otgonbat A; Zhao M Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830 [TBL] [Abstract][Full Text] [Related]
25. CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration. Harada N; Mukai D; Izuta Y; Shibano I; Kizawa Y; Shiragami H; Ohnishi N; Hosaka N; Mugitani A Pathol Int; 2024 Feb; 74(2):93-95. PubMed ID: 38050833 [No Abstract] [Full Text] [Related]
26. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form. Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046 [TBL] [Abstract][Full Text] [Related]
27. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice. Tefferi A; Elliott M; Pardanani A Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036 [TBL] [Abstract][Full Text] [Related]
28. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I. Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333 [TBL] [Abstract][Full Text] [Related]
29. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia. Gao J; Han S; Deng B; Deng Y; Gao X Ann Hematol; 2024 Aug; 103(8):2591-2600. PubMed ID: 37993585 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950 [TBL] [Abstract][Full Text] [Related]
31. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes. Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996 [TBL] [Abstract][Full Text] [Related]
32. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review]. Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis. Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286 [TBL] [Abstract][Full Text] [Related]
34. Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib. Ammatuna E; Eefting M; van Lom K; Kavelaars FG; Valk PJ; Touw IP Ann Hematol; 2015 May; 94(5):879-80. PubMed ID: 25491280 [No Abstract] [Full Text] [Related]